Dr Reddy's Laboratories has launched a first-in-class drug to treat chronic constipation. The company will market the drug under the brand name BixiBat in India. The launch follows approval granted to the company by the Central Drugs Standard Control Organisation (CDSCO). Dr Reddy's is the first company to receive approval for and launch such a drug (Elobixibat) in India.
Elobixibat acts by inhibiting the reabsorption of bile acids from the ileum, thus increasing their concentration in the colonic lumen, leading to increased bowel movements due to stimulation of both colonic motility and fluid secretion irrespective of the transit speed.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
